Earth Science Tech (ETST) Receivables - Other (2014 - 2023)
Earth Science Tech (ETST) posted Receivables - Other of $118000.0 for Q3 2023, down 54.94% on a QoQ basis from $261871.0 in Q2 2023, and down 45.99% year-over-year from $218462.0 in Q3 2022.
Earth Science Tech (ETST) Receivables - Other (2014 - 2023) Analysis & Trends
Earth Science Tech's Receivables - Other history runs 3 years deep, the most recent figure standing at $118000.0 for Q3 2023.
- Quarterly Receivables - Other fell 45.99% year-over-year to $118000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $118000.0 (down 45.99% YoY) and the FY2023 annual result came in at $310947.0, down 46.93% from the prior year.
- Receivables - Other was $118000.0 for Q3 2023 at Earth Science Tech, down from $261871.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $585886.0 in Q1 2022 and bottomed at $20000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Earth Science Tech | 41.03 Mn | 38.90 Mn | 6.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 118,000.00 |
| Sep 30, 2023 | 118,000.00 |
| Jun 30, 2023 | 261,871.00 |
| Jun 30, 2023 | 261,871.00 |
| Mar 31, 2023 | 310,947.00 |
| Mar 31, 2023 | 310,947.00 |
| Dec 31, 2022 | 158,846.00 |
| Dec 31, 2022 | 158,846.00 |
| Sep 30, 2022 | 218,462.00 |
| Sep 30, 2022 | 218,462.00 |
| Jun 30, 2022 | 20,000.00 |
| Jun 30, 2022 | 20,000.00 |
| Mar 31, 2022 | 585,886.00 |
| Mar 31, 2022 | 585,886.00 |
| Sep 30, 2014 | 59,558.00 |
| Sep 30, 2014 | 59,558.00 |
| Jun 30, 2014 | 59,558.00 |
| Jun 30, 2014 | 59,558.00 |
| Mar 31, 2014 | 38,605.00 |
| Mar 31, 2014 | 38,605.00 |